CAI Q3 2019 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$108M-6.8% YoY

Gross Profit

$52M48.1% margin

Operating Income

$34M32.0% margin

Net Income

-$5M-4.4% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$72M

Free Cash Flow

-$18M

Stock-Based Comp.

$741,000

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$686M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$108M	$115M	-6.8%
Gross Profit	$52M	$57M	-8.6%
Operating Income	$34M	$40M	-14.5%
Net Income	-$5M	$22M	-121.8%